Ben Dorks
About Ben Dorks
Ben Dorks is the Chief Executive Officer of Ideagen, where he has worked since 2013, holding various leadership roles including Chief Customer Officer. He has a strong background in commercial growth strategies, software development, and managing acquisitions, and he emphasizes communication and collaboration to enhance performance.
Current Role at Ideagen Plc
Ben Dorks has served as the Chief Executive Officer of Ideagen since 2018. In this role, he oversees the company's strategic direction and operational management. Dorks has been pivotal in fostering a performance-led culture within the organization, focusing on continuous transformation plans. His leadership emphasizes the importance of communication, collaboration, and coaching to enhance overall performance. Under his guidance, Ideagen has aimed to achieve double-digit organic growth.
Previous Experience at Ideagen
Before becoming CEO, Ben Dorks held several key positions at Ideagen. He served as the Chief Customer Officer from 2016 to 2018, where he managed the total relationship with Ideagen's customers, overseeing global sales, marketing, product, and professional services. Prior to that, he was the Group Sales & Marketing Director from 2013 to 2016. Dorks joined Ideagen through the acquisition of Plumtree Group, where he had previously worked as Sales & Marketing Director.
Background and Education
Ben Dorks studied at Ratcliffe College from 1986 to 1991. He has a strong technical understanding of software development and its application in various vertical markets. His educational background has contributed to his ability to create and manage commercial growth strategies effectively.
Experience in Commercial Growth Strategies
Dorks has a robust background in developing and managing commercial growth strategies that achieve double-digit organic growth. His experience includes managing acquisitions with a total enterprise value of up to $200 million. This expertise has been instrumental in driving growth and transformation at Ideagen.